Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

Recent & Breaking News (GREY:LXXGQ)

LexaGene Advances Towards FDA Emergency Use Authorization

GlobeNewswire July 2, 2021

LexaGene Announces Fourth Quarter and Full-Year End February 28, 2021, Financial Results

GlobeNewswire June 29, 2021

LexaGene Engages LaVoieHealthScience as Integrated Investor and Public Relations Agency of Record

GlobeNewswire June 28, 2021

LexaGene (TSXV:LXG) sells MiQLab system for early diagnostic testing in veterinarian practices

Julia Kennedy  June 24, 2021

New Sale of LexaGene's MiQLab(TM) System Propels Early Diagnostic Testing in Veterinarian Practices

GlobeNewswire June 24, 2021

LexaGene's MiQLab Offers Rapid Plague Detection for Bioterrorism Threats

GlobeNewswire June 17, 2021

LexaGene (TSXV:LXG) closes sale to Alpine Veterinary Hospital

John Ballem  June 14, 2021

LexaGene Closes Sale to Alpine Veterinary Hospital

GlobeNewswire June 14, 2021

LexaGene’s (TSXV:LXG) MiQLab System detects bacterium 36 times faster than other methods

Jocelyn Aspa June 10, 2021

LexaGene detects a slow-growing bacterium at least 36-times faster than conventional methods with the potential to increase vaccine safety and supply

GlobeNewswire June 10, 2021

LexaGene Sells a MiQLab System to Denver Animal Emergency

GlobeNewswire June 7, 2021

LexaGene Partners with Ethos Discovery to Develop New Companion Animal Diagnostic Tests

GlobeNewswire June 3, 2021

LexaGene Takes Steps to List on the Nasdaq

GlobeNewswire June 1, 2021

LexaGene Expands its Sales Team

GlobeNewswire May 11, 2021

LexaGene Hosts a Seminar to Present MiQLab Data from Veterinary Samples

GlobeNewswire April 14, 2021

LexaGene's Provides Corporate Update

GlobeNewswire April 1, 2021

LexaGene Receives $3.6M from the Exercise of Warrants

GlobeNewswire March 2, 2021

LexaGene Announces Change in Management and Appoints New Member to the Board of Directors

GlobeNewswire February 12, 2021

LexaGene’s (TSXV:LXG) MiQLab successfully detects Mutant UK and South African COVID-19 sequences

Isabella Zavarise February 10, 2021

LexaGene's MiQLab Successfully Detects Mutant UK and South African COVID-19 Sequences

GlobeNewswire February 10, 2021